Transdermal Drug Delivery System Market Growth Scope 2030
The transdermal drug delivery system market is expected to grow from US$ 37,230.28 million in 2022 to US$ 51,949.74 million by 2030; it is anticipated to record a CAGR of 4.3% from 2022 to 2030. Strategic initiatives by manufacturers will likely remain a key trend in the market.
Transdermal Drug Delivery System Market Analysis
The increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery devices, and high demand for self-administration of drugs are the key driving factors behind the market growth. Furthermore, adopting 3D printing technology and smart patches will likely offer opportunities to the transdermal drug delivery systems market in the coming years.
Transdermal Drug Delivery System Market Overview
Cardiovascular diseases (CVDs) such as angina, atherosclerosis, pectoris, and acute myocardial infarction are among the common causes of mortality in the world. According to the WHO, CVDs are the major cause of ~17.9 million deaths worldwide every year. Many medicines are commercially available for the treatment of CVDs, but conventional capsules and tablets are unable to control the ailment effectively. This underlines the need for novel drug delivery systems providing prolonged drug bioavailability and targeted drug delivery to the affected areas of the cardiovascular system. Transdermal drug delivery systems offer many advantages over regular orally administered drugs to treat cardiovascular diseases. Transdermal patches, encompassing drug particles, are applied on the skin surface. A cardiac patch provides an excellent platform for cell engraftment improvement. For example, a vascularized cardiac patch developed recently shows promising potential for treating ischemic heart injuries. Nitroglycerin transdermal patches are used to prevent angina (chest pain) episodes in people with coronary artery disease. They work by relaxing the blood vessels and reducing the heart's stress, lowering the need for oxygen. However, these patches cannot be used to treat angina attacks that have already begun.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Transdermal Drug Delivery System Market: Strategic Insights
Market Size Value in US$ 37,230.28 million in 2022 Market Size Value by US$ 51,949.74 million by 2030 Growth rate CAGR of 4.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Transdermal Drug Delivery System Market: Strategic Insights
| Market Size Value in | US$ 37,230.28 million in 2022 |
| Market Size Value by | US$ 51,949.74 million by 2030 |
| Growth rate | CAGR of 4.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Transdermal Drug Delivery System Market Drivers and Opportunities
Continuous Technological Advancement
Traditional drug delivery techniques such as intramuscular, intravenous, and rectal drug administration are not preferred by specific patient populations, mainly due to the pain and complexities associated with them. With the improvements in medical science and definite drug delivery technologies, noninvasive drug delivery systems are now set to compete with the traditional method of injectable drug administration. The noninvasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), and transdermal-passive; transocular membrane, transmucosal membrane, and alveolar membrane from inhaled medication. Transdermal drug delivery is advantageous in many ways over the oral route of administration. In particular, it evades the first-pass mechanism of the liver, which can otherwise impulsively metabolize drugs.
Advancements in Smart Patches and 3D-printed Patches
A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, many transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.
Transdermal Drug Delivery System Market Report Segmentation Analysis
Key segments that contributed to the derivation of the transdermal drug delivery system market analysis are product and end user.
- Based on type, the transdermal drug delivery system market is segmented into event transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal patches segment held the largest market share in 2022.
- Based on application, the transdermal drug delivery system market is segmented by cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, other applications. The pain management segment held a largest market share in 2022.
- Based on the distribution channel, the transdermal drug delivery system market is segmented by hospitals pharmacies, retail phamacies, online pharmacies, others. The hospitals pharmacies segment held a largest market share in 2022.
Transdermal Drug Delivery System Market Share Analysis by Geography
The geographic scope of the transdermal drug delivery system market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The US is the largest market for transdermal drug delivery systems in North America. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, patient monitoring, and compliance. According to a report titled "Recent advances in transdermal drug delivery systems," published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases..
Transdermal Drug Delivery System Market Report Scope
Transdermal Drug Delivery System Market News and Recent Developments
The Transdermal Drug Delivery System Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the transdermal drug delivery system market are listed below:
- Starton Therapeutics Inc. has filed provisional patent applications with the U.S. Patent and Trademark Office (USPTO) for unique and novel approaches to incorporate various active pharmaceutical ingredients (APIs) into transdermal drug delivery systems, where such APIs have typically been difficult to incorporate in a transdermal drug delivery system platform. (Source: Starton Therapeutics, Company Website, January 2024)
- Satio has received a $3.5 million Small Business Innovation Research (SBIR) contract from Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services. This SatioRx device is designed to be compact and inexpensive, with disposable microneedle components that allow healthcare providers to remotely deliver a precise metered dose of any liquid drug approved for transdermal delivery by the FDA. Under this contract, Satio will leverage design features from its other patch-based devices and feasibility data from its manually operated transdermal delivery devices to develop the next-generation remotely controllable device. (Source: Satio, Company Website, September 2023)
Transdermal Drug Delivery System Market Report Coverage and Deliverables
The “Transdermal Drug Delivery System Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Transdermal drug delivery system market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Transdermal drug delivery system market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Transdermal drug delivery system market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the transdermal drug delivery system market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.3% during 2023–2031.
Novartis AG, GSK Plc, Viatris Inc, Boehringer Ingelheim International GmbH, Lavipharm SA, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Purdue Pharma LP.
Strategic initiatives by manufacturers will likely remain a key trend in the market.
The increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery devices, and high demand for self-administration of drugs are the key driving factors behind the market growth.
North America dominated the transdermal drug delivery system market in 2023
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. Transdermal Drug Delivery System Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Advancements in Smart Patches and 3D-Printed Patches
5.4 Future Trends
5.4.1 Strategic Initiatives by Manufacturers
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market - Global Market Analysis
6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
7. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Transdermal Patches
7.3.1 Overview
7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Drug-in-Adhesive Patches
7.3.2.1.1 Overview
7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Matrix Patches
7.3.2.2.1 Overview
7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.3 Reservoir Membrane Patches
7.3.2.3.1 Overview
7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.4 Vapor Patches
7.3.2.4.1 Overview
7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Transdermal Gels
7.4.1 Overview
7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Transdermal Sprays
7.5.1 Overview
7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Opioid
8.5.2.1.1 Overview
8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.2 Non-Opioid
8.5.2.2.1 Overview
8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.1 Transdermal Estrogen & Progesterone Therapy
8.6.2.1.1 Overview
8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.2 Testosterone Replacement
8.6.2.2.1 Overview
8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Application
8.7.1 Overview
8.7.2 Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 North America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.1 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Transdermal Drug Delivery System Market
10.2.1 Overview
10.2.2 Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.2.6.1 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.3 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.4 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.5 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Transdermal Drug Delivery System Market
10.3.1 Overview
10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.3.6.1 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.3 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.4 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.5 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Transdermal Drug Delivery System Market
10.4.1 Overview
10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.1 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.3 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Transdermal Drug Delivery System Market
10.5.1 Overview
10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
10.5.6.1 Brazil: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.1.1 Overview
10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.3 Argentina: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.3.1 Overview
10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.5.1 Overview
10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
11. Transdermal Drug Delivery System Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Transdermal Drug Delivery System Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GSK Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Viatris Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Boehringer Ingelheim International GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Luye Pharma Group Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lavipharm SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Purdue Pharma LP
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 UCB SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Transdermal Drug Delivery System Market Segmentation
Table 2. North America Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Germany Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. Germany Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. France Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. France Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 40. France Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 41. France Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 42. France Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 43. France Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 44. UK Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. UK Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 46. UK Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 47. UK Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 48. UK Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. UK Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 62. Rest of Europe Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Rest of Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 68. Asia Pacific Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 74. China Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. China Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 76. China Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 86. India Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. India Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 88. India Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 89. India Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 99. South Korea Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 103. South Korea Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 110. Middle East & Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 116. South Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 117. South Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 118. South Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 119. South Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 120. South Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 121. South Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 124. Saudi Arabia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 125. Saudi Arabia Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 126. Saudi Arabia Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 127. Saudi Arabia Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 130. UAE Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 131. UAE Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 132. UAE Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 133. UAE Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 140. South & Central America: Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 141. South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America: Transdermal Drug Delivery System Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 146. Brazil Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 147. Brazil Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 152. Argentina Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 153. Argentina Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 158. Rest of South & Central America Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 159. Rest of South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 164. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 165. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 166. Glossary of Terms, Transdermal Drug Delivery System Market
List of Figures
Figure 1. Transdermal Drug Delivery System Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 4. Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 5. Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Transdermal Drug Delivery System Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 27. Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 32. North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. North America: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 34. US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Europe: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Europe Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 40. Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 49. China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 55. Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 56. Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 57. Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 58. South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 59. Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. South & Central America: Transdermal Drug Delivery System Market, By Key Country – Revenue (2022) (US$ Million)
Figure 63. South & Central America: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 64. South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
Figure 65. Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 66. Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 67. Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 68. Growth Strategies in the Transdermal Drug Delivery System Market
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For